Cancer incidence in persons with Down syndrome in Israel.

Lital Keinan Boker, Joav Merrick

Research output: Contribution to journalArticlepeer-review

Abstract

The purpose of this study was to assess the incidence rates of leukaemia and other malignancies in persons with Down syndrome in Israel. The target population consisted of all persons with Down syndrome in the period of 1948-1995 and the study population was divided into two subgroups: (1) Persons born in Israel between 1979-95 (registry group) and (2) Persons currently or past-institutionalised, born before 1979 (institution group). The study population was linked to the Cancer Registry and cases that had been diagnosed through December 1995 were subsequently identified. The observed incidence rates were compared to expected rates in the general population. Standardised Incidence Ratios (SIR) and 95% confidence intervals were computed for each disease category. Analyses of results were performed separately for each subgroup of our study population. In the registry group seven cancer cases were observed as compared to 1.5 expected (SIR = 4.67 95% CI 1.9-9.6), all of which were leukaemia cases. For the institution group a total of 17 cancer cases were observed compared to 12.8 expected. These included four cases of leukaemia (SIR = 6.90 95% CI 1.9-17.7). An excess of gastric cancer in males, based on two cases (SIR = 11.9 95% CI 1.3-42.9) was also observed. The significant excess of leukaemia in the Down syndrome population in Israel is in accordance with other international studies. The excess of gastric cancer in males with Down syndrome, which has not been reported before, should be further explored.

Original languageEnglish
Pages (from-to)31-36
Number of pages6
JournalDown's syndrome, research and practice : the journal of the Sarah Duffen Centre / University of Portsmouth
Volume8
Issue number1
DOIs
StatePublished - Mar 2002
Externally publishedYes

ASJC Scopus subject areas

  • Medicine (all)

Fingerprint

Dive into the research topics of 'Cancer incidence in persons with Down syndrome in Israel.'. Together they form a unique fingerprint.

Cite this